Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.003
Neutral
RSI(14)
67.873
Neutral
STOCH(KDJ)(9,3,3)
74.380
Buy
ATR(14)
0.179
High Vlolatility
CCI(14)
83.963
Neutral
Williams %R
1.613
Overbought
TRIX(12,20)
1.174
Sell
StochRSI(14)
69.139
Buy
Search
Spectral AI Inc
MDAIAdd to Watchlist
2.440USD
+0.310+14.55%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
66.49MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Spectral AI Inc
Currency: USD Updated: 2026-05-14Key Insights
Spectral AI Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 123 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 4.67.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Spectral AI Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Spectral AI Inc Highlights
StrengthsRisks
Spectral AI, Inc. is a predictive artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. It is non-invasive, non-radiation, non-laser and does not require the use of injectable dye. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid healthcare providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.
Growing
The company is in a growing phase, with the latest annual income totaling USD 19.65M.
Undervalued
The company’s latest PE is -4.10, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 5.59M shares, increasing 6.17% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 0.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.46.
Analyst Rating
Based on
2
analysts
Strong Buy
Current Rating
4.667
Target Price
+128.76%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-14The current financial score of Spectral AI Inc is 6.06, ranking 170 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 3.99M, representing a year-over-year decrease of 40.50%, while its net profit experienced a year-over-year decrease of 217.78%.
Score
Financials
7.09
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.16
Operational Efficiency
4.76
Growth Potential
4.23
Shareholder Returns
7.08
Spectral AI Inc's Company Valuation
Currency: USD Updated: 2026-05-14The current valuation score of Spectral AI Inc is 6.73, ranking 151 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -4.10, which is -100.00% below the recent high of 0.00 and -1292.66% above the recent low of -57.16.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 123/206
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-14The current earnings forecast score of Spectral AI Inc is 9.00, ranking 8 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 5.50, with a high of 7.45 and a low of 3.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
2
analysts
Strong Buy
Current Rating
4.667
Target Price
+128.76%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
93
Total
4
Median
7
Average
Company name
Ratings
Analysts
Spectral AI Inc
MDAI
2
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-14The current price momentum score of Spectral AI Inc is 5.46, ranking 178 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 2.46 and the support level at 1.76, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
2.216
Buy
MA10
2.240
Buy
MA20
2.082
Buy
MA50
1.767
Buy
MA100
1.658
Buy
MA200
1.832
Buy
Institutional Confidence
Currency: USD Updated: 2026-05-14The current institutional shareholding score of Spectral AI Inc is 3.00, ranking 133 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 17.74%, representing a quarter-over-quarter increase of 71.60%. The largest institutional shareholder is The Vanguard, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 100.00% decrease in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-05-14The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Spectral AI Inc is 2.58, ranking 152 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.16. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
1.16
VaR
--
240-Day Maximum Drawdown
+61.78%
240-Day Volatility
+81.42%
Return
Best Daily Return
60 days
+18.33%
120 days
+18.33%
5 years
--
Worst Daily Return
60 days
-7.73%
120 days
-7.73%
5 years
--
Sharpe Ratio
60 days
+2.19
120 days
+1.53
5 years
--
Risk Assessment
Maximum Drawdown
240 days
+61.78%
3 years
+100.00%
5 years
+100.00%
Return-to-Drawdown Ratio
240 days
+0.54
3 years
-0.27
5 years
-0.16
Skewness
240 days
+0.75
3 years
+0.42
5 years
--
Volatility
Realised Volatility
240 days
+81.42%
5 years
--
Standardised True Range
240 days
+6.74%
5 years
+43.42%
Downside Risk-Adjusted Return
120 days
+311.75%
240 days
+311.75%
Maximum Daily Upside Volatility
60 days
+66.83%
Maximum Daily Downside Volatility
60 days
+45.99%
Liquidity
Average Turnover Rate
60 days
+2.87%
120 days
+2.05%
5 years
--
Turnover Deviation
20 days
-46.16%
60 days
-16.31%
120 days
-40.41%
Peer Comparison
Healthcare Equipment & Supplies
Spectral AI Inc
MDAI
5.97 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.73 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
ANIK
8.60 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.40 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
8.36 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
BRKR
8.27 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
